Title : Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.

Pub. Date : 2019 Apr

PMID : 30760018






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Current guidelines recommend dual antiplatelet therapy-a P2Y12 inhibitor (clopidogrel, prasugrel, or ticagrelor) and aspirin-for patients undergoing percutaneous coronary intervention. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens